Acetabular dysplasia and osteoarthritis of the hip in elderly white women

Article Abstract:

A condition called acetabular dysplasia characterized by abnormal central bone angles in the hip socket does not appear to be a risk factor for developing osteoarthritis (OA) of the hip. Pelvic x-rays of 165 older women with hip OA and 88 older women without hip OA were evaluated for signs of acetabular dysplasia. Overall, 13.2% of the women had evidence of acetabular dysplasia. Women with OA were only 1.33 times more likely than women without OA to have acetabular dysplasia.

Osteoarthritis, Hip joint, Hip dislocation, Congenital hip dysplasia

---

Effects of Infant Birthweight and Maternal Body Mass Index in Pregnancy on Components of the Insulin Resistance Syndrome in China

Article Abstract:

The offspring of women who were undernourished before and during pregnancy may have a higher risk of insulin resistance. Insulin resistance is a precursor of diabetes. In a study of 627 men and women in China, those whose mothers were very thin before pregnancy were likely to have insulin resistance. Low birth weight was also a risk factor for insulin resistance.

Health aspects, Food and nutrition, Pregnant women, Birth weight, Low, Low birth weight, Insulin resistance

---

Similar abstracts:

• Abstracts: Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials
• Abstracts: Factors associated with early maternal postpartum discharge from the hospital
• Abstracts: The hepatorenal syndrome - newer perspectives. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
• Abstracts: Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women
• Abstracts: Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing. European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.